Related Experiment Video

Updated: May 22, 2026

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
11:05

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

Published on: January 7, 2019

Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth

Yan-Bo Liu1, Ling Zhang, Ya-Xiong Guo

  • 1Prostate Diseases Prevention and Treatment Research Centre and Department of Pathophysiology, Norman Bethune Medical School, Jilin University, Changchun130021, China.

Asian Journal of Andrology
|May 15, 2012
PubMed

Insights

Targeting Survivin with short hairpin RNA (shRNA) combined with GRIM-19 gene therapy offers a potent new strategy for prostate cancer treatment. This dual approach synergistically inhibits tumor growth and survival more effectively than single agents.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Survivin overexpression drives cancer formation, progression, and metastasis.
  • Survivin is a validated target for RNA interference (RNAi)-mediated cancer growth inhibition.
  • Prostate tumor growth can be significantly reduced by blocking Survivin using specific short hairpin RNAs (shRNAs).

Purpose of the Study:

  • To enhance the therapeutic efficacy of Survivin-specific shRNA for prostate cancer treatment.
  • To investigate the synergistic effects of combining Survivin-specific shRNA with the gene associated with retinoid-interferon-induced mortality-19 (GRIM-19).

Main Methods:

  • Constructed a dual expression plasmid vector encoding both GRIM-19 and Survivin-specific shRNAs.
  • Utilized an attenuated strain of Salmonella enterica serovar Typhimurium (S. typhimurium) for targeted delivery of the therapeutic vector.
  • Evaluated the efficacy of the combined therapy in vitro and in vivo models of prostate cancer.

Main Results:

  • Co-expression of Survivin-specific shRNA and GRIM-19 synergistically inhibited prostate tumor proliferation and survival.
  • The combined therapy demonstrated significantly greater efficacy compared to either agent alone.
  • Successful in vitro and in vivo inhibition of prostate tumor growth was observed.

Conclusions:

  • Combined Survivin-specific shRNA and GRIM-19 gene therapy presents a novel and effective therapeutic approach for prostate cancer.
  • This combinatorial strategy overcomes limitations of single-agent RNA interference.
  • The study provides a promising new avenue for cancer gene therapy development.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...